New Biosynthesis Platform Could Enable Bioactive Compounds to be Labeled, Targeted and Released on Demand

Researchers have developed a new biosynthesis platform that allows bioactive compounds to be labeled, targeted, and released on demand. This breakthrough could revolutionize how medically important drugs are produced from natural sources using precise enzymatic assembly lines. The technology promises to accelerate the discovery and deployment of life-saving treatments derived from microorganisms.